{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:19:31Z","timestamp":1790961571844,"version":"4.1.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Eastern Finland (UEF) including Kuopio University Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute pyelonephritis is a common infection in children that may cause renal scarring. The aim of this systematic review and meta-analysis was to analyse the use of corticosteroid treatment to prevent renal scarring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched the PubMED, SCOPUS, Cochrane CENTRAL and Web of Science databases in June 2022 for (corticosteroid* or dexamethasone or prednisolone* or prednisone* or hydrocortisone*) AND pyelonephritis. Randomised controlled trials focusing on children were included. The intervention was corticosteroid treatment with antibiotics compared to antibiotics with or without a placebo. The main outcome was the presence of renal scars on dimercaptosuccinic acid scanning at follow-up. The evidence quality was assessed using the GRADE methodology and risk of bias 2.0 tool. We calculated the risk ratio (RR), absolute risk difference (RD) with 95% confidence intervals (CI) and the number needed to treat (NNT). We applied a fixed effects model due to low heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We screened 872 abstracts and included five full texts. Renal scarring at follow-up was found in 31\/220 (14.1%) patients in the corticosteroid groups and 76\/278 (27.3%) in the control groups (RR 0.65, CI 0.44\u20130.96, RD\u2009\u2212\u200913.2%, NNT 8). The evidence quality was moderate. Two studies reported adverse events with no differences between the groups. The risk of bias analysis showed some concerns in four studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We found moderate quality evidence that adjuvant corticosteroid treatment could prevent renal scarring. Adverse events were insufficiently reported, and more research on their effectiveness and harm is therefore needed before using corticosteroids in clinical settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40620-022-01552-1","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T11:59:26Z","timestamp":1674561566000},"page":"1509-1518","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Corticosteroids to prevent renal scarring in children with pyelonephritis: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9520-7383","authenticated-orcid":false,"given":"Johanna","family":"J\u00e4\u00e4skel\u00e4inen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjo","family":"Renko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilari","family":"Kuitunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,1,24]]},"reference":[{"issue":"7","key":"1552_CR1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/apa.12992","volume":"104","author":"F Ladomenou","year":"2015","unstructured":"Ladomenou F, Bitsori M, Galanakis E (2015) Incidence and morbidity of urinary tract infection in a prospective cohort of children. Acta Paediatr 104(7):324. https:\/\/doi.org\/10.1111\/apa.12992","journal-title":"Acta Paediatr"},{"issue":"1","key":"1552_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1872213X13666181228154940","volume":"13","author":"AKC Leung","year":"2019","unstructured":"Leung AKC, Wong AHC, Leung AAM, Hon KL (2019) Urinary tract infection in children. Recent Pat Inflamm Allergy Drug Disc 13(1):2\u201318. https:\/\/doi.org\/10.2174\/1872213X13666181228154940","journal-title":"Recent Pat Inflamm Allergy Drug Disc"},{"issue":"6","key":"1552_CR3","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1542\/peds.2010-0685","volume":"126","author":"N Shaikh","year":"2010","unstructured":"Shaikh N, Ewing AL, Bhatnagar S, Hoberman A (2010) Risk of renal scarring in children with a first urinary tract infection: a systematic review. Pediatrics 126(6):1084. https:\/\/doi.org\/10.1542\/peds.2010-0685","journal-title":"Pediatrics"},{"issue":"6701","key":"1552_CR4","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/bmj.299.6701.703","volume":"299","author":"SH Jacobson","year":"1989","unstructured":"Jacobson SH, Ekl\u00f6f O, Eriksson CG, Lins LE, Tidgren B, Winberg J (1989) Development of hypertension and uraemia after pyelonephritis in childhood: 27 year follow up. BMJ 299(6701):703\u2013706. https:\/\/doi.org\/10.1136\/bmj.299.6701.703","journal-title":"BMJ"},{"key":"1552_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/00004872-200018040-00019","volume":"18","author":"M Wennerstro","year":"2000","unstructured":"Wennerstro M, Hansson S, Hedner T, Himmelmann A, Jodal U (2000) Ambulatory blood pressure 16 \u00b1 26 years after the \u00aerst urinary tract infection in childhood. J Hypertens 18:485","journal-title":"J Hypertens"},{"key":"1552_CR6","doi-asserted-by":"publisher","unstructured":"Lin K, Chiu N, Chen M, et al (2003) Acute pyelonephritis and sequelae of renal scar in pediatric first febrile urinary tract infection. Pediatr Nephrol (Berlin, West). 18(4):362\u2013365. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12700963. https:\/\/doi.org\/10.1007\/s00467-003-1109-1","DOI":"10.1007\/s00467-003-1109-1"},{"issue":"11","key":"1552_CR7","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1136\/archdischild-2020-320591","volume":"106","author":"J Meena","year":"2021","unstructured":"Meena J, Kumar J (2021) Adjuvant corticosteroids for prevention of kidney scarring in children with acute pyelonephritis: a systematic review and meta-analysis. Arch Dis Child 106(11):1081\u20131086. https:\/\/doi.org\/10.1136\/archdischild-2020-320591","journal-title":"Arch Dis Child"},{"key":"1552_CR8","doi-asserted-by":"publisher","unstructured":"Guyatt GH, Oxman AD, Vist GE et al. (2008) GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336(7650):924\u2013926. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2335261\/. Accessed Jul 17, 2022. https:\/\/doi.org\/10.1136\/bmj.39489.470347.AD","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"1552_CR9","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (2022) Cochrane handbook for systematic reviews of interventions version 6.3. . www.training.cochrane.org\/handbook. https:\/\/training.cochrane.org\/handbook\/current. Updated 2022"},{"key":"1552_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l6890","author":"M Campbell","year":"2020","unstructured":"Campbell M, Mckenzie JE, Sowden A et al (2020) Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. https:\/\/doi.org\/10.1136\/bmj.l6890","journal-title":"BMJ"},{"key":"1552_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2021","unstructured":"Page MJ, Mckenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"issue":"3","key":"1552_CR12","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1542\/peds.2010-0297","volume":"128","author":"YY Huang","year":"2011","unstructured":"Huang YY, Chen MJ, Chiu NT, Chou HH, Lin KY, Chiou YY (2011) Adjunctive oral methylprednisolone in pediatric acute pyelonephritis alleviates renal scarring. Pediatrics 128(3):496. https:\/\/doi.org\/10.1542\/peds.2010-0297","journal-title":"Pediatrics"},{"issue":"4","key":"1552_CR13","first-page":"244","volume":"13","author":"J Ghaffari","year":"2019","unstructured":"Ghaffari J, Mohammadjafari H, Mohammadi GH, Mahdavi MR (2019) Assessment the effect of dexamethasone on urinary cytokines and renal scar in children with acute pyelonephritis. Iran J Kidney Dis 13(4):244\u2013250 (4318\/1078[pii])","journal-title":"Iran J Kidney Dis"},{"issue":"11","key":"1552_CR14","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1007\/s00467-020-04622-3","volume":"35","author":"N Shaikh","year":"2020","unstructured":"Shaikh N, Shope TR, Hoberman A et al (2020) Corticosteroids to prevent kidney scarring in children with a febrile urinary tract infection: a randomized trial. Pediatr Nephrol 35(11):2113\u20132120. https:\/\/doi.org\/10.1007\/s00467-020-04622-3","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"1552_CR15","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1007\/s00467-021-05117-5","volume":"36","author":"L Da Dalt","year":"2021","unstructured":"Da Dalt L, Bressan S, Scozzola F et al (2021) Oral steroids for reducing kidney scarring in young children with febrile urinary tract infections: the contribution of Bayesian analysis to a randomized trial not reaching its intended sample size. Pediatr Nephrol 36(11):3681\u20133692. https:\/\/doi.org\/10.1007\/s00467-021-05117-5","journal-title":"Pediatr Nephrol"},{"key":"1552_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-021-05398-w","author":"N Rius-Gordillo","year":"2022","unstructured":"Rius-Gordillo N, Ferre N, Gonzalez JD et al (2022) Dexamethasone to prevent kidney scarring in acute pyelonephritis: a randomized clinical trial. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-021-05398-w","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"1552_CR17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1001\/archpedi.154.4.339","volume":"154","author":"M Wennerstr\u00f6m","year":"2000","unstructured":"Wennerstr\u00f6m M, Hansson S, Jodal U, Sixt R, Stokland E (2000) Renal function 16\u201326 years after the first urinary tract infection in childhood. Arch Pediatr Adolesc Med 154(4):339\u2013345. https:\/\/doi.org\/10.1001\/archpedi.154.4.339","journal-title":"Arch Pediatr Adolesc Med"},{"key":"1552_CR18","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-0610","author":"M Honkila","year":"2020","unstructured":"Honkila M, Hannula A, Pokka T et al (2020) Childhood urinary tract infections and pregnancy-related complications in adult women. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2020-0610","journal-title":"Pediatrics"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-022-01552-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-022-01552-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-022-01552-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:52:30Z","timestamp":1777564350000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/36\/6\/1509\/8304147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,24]]},"references-count":18,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["1552"],"URL":"https:\/\/doi.org\/10.1007\/s40620-022-01552-1","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,24]]},"assertion":[{"value":"12 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No financial or non-financial benefits have been or will be received from any party related directly or indirectly to the subject of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}